Clinical Trial Update: GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

View source ↗

Summary

A clinical trial evaluating the natural progression of dry age-related macular degeneration (AMD) sponsored by Gyroscope Therapeutics Limited was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy
• Macular Atrophy

Snippet

Sponsor: Gyroscope Therapeutics Limited | Conditions: Dry Age-related Macular Degeneration, Macular Degeneration | Status: TERMINATED